A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)

Procter & Gamble (P&G)

Status

Completed

Conditions

Stress Urinary Incontinence (SUI)

Treatments

Device: disposable, single-use pessary

Study type

Interventional

Funder types

Industry

Identifiers

NCT02131311

2012118

Details and patient eligibility

About

This study will evaluate the effectiveness of the pessary device by assessing reduction in urine leakage in approximately 80 women with SUI. Efficacy will be assessed by pad weight gain, frequency of stress urinary incontinence events, and a quality of life questionnaire.

Enrollment

145 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

be female 18 years or older;
provide written informed consent prior to study participation and receive a signed copy;
be in generally good health as determined by the Investigator;
have a ≥ 3 month history of experiencing SUI (self reported);
be willing to use the pessary investigational device to control stress urinary incontinence;
be willing to comply with study requirements and instructions;

Exclusion criteria

pregnant, lactating or planning to become pregnant during the study;
within 3 months post partum;
intrauterine device (IUD) placement of less than 6 months;
has self-reported difficulty emptying her bladder;
a history of Toxic Shock Syndrome (TSS) or symptoms consistent with TSS;
experience difficulty inserting or wearing an intra-vaginal device, including a tampon;
vaginal surgery, perineal surgery, uterine surgery, or abortion (spontaneous or induced) within the past 3 months;
has any Screening laboratory value outside the laboratory reference range considered clinically significant by the Investigator which could impact the safety of the subject or the outcome of the study;
for any reason, the Investigator decides that the subject should not participate in the study.